The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion

Spine Journal

Volumn 8, Issue 3, 2008, Pages 443-448

  Glassman, Steven D ^a,b   Carreon, Leah Y ^b   Campbell, Mitchell J ^a,b   Johnson, John R ^a,b   Puno, Rolando M ^a,b   Djurasovic, Mladen ^a,b   Dimar, John R ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NORTON LEATHERMAN SPINE CENTER   (United States)

Author keywords

Economics; Iliac crest bone graft; Infuse; Lumbar fusion; RhBMP 2

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; ARTICLE; BONE GRAFT; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSIS RELATED GROUP; FEMALE; FOLLOW UP; FUNDING; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; ILIAC CREST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OUTPATIENT CARE; PRIORITY JOURNAL; REHABILITATION CARE; SPINE FUSION;

AGED; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; FEMALE; HUMANS; ILIUM; LUMBOSACRAL REGION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; SPINAL FUSION;

EID: 42949169545     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2007.03.004     Document Type: Article

References (22)

1. Burkus J.K., Sandhu H.S., Gornet M.F., and Longley M.C. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87 (2005) 1205-1212
2. Burkus J.K., Heim S.E., Gornet M.F., and Zdeblick T.A. The Effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 27 (2004) 723-728
3. Burkus J.K., Transfeldt E.E., Kitchel S.H., Watkins R.G., and Balderston R.A. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27 (2002) 2396-2408
4. Glassman S.D., Carreon L., Djurasovic M., et al. Posterolateral lumbar spine fusion with Infuse bone graft. Spine J 7 (2007) 44-49
5. Singh K., Smucker J.D., and Boden S.D. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disorder Tech 19 (2006) 416-423
6. Alexander D.I., Abraham E.P., Bailey S.I., et al. A new rhBMP-2 formulation in posterolateral lumbar spine fusion; a prospective, randomized study. Proceedings of the American Academy of Orthopaedic Surgeons Annual Meeting 6 (2005) 532
7. St. John T.A., Vaccaro A.R., Sah A.P., Schaefer M., Berta S.C., Albert T., and Hilibrand A. Physical and monetary costs associated with autogenous bone graft harvesting. Am J Orthop 32 (2003) 18-23
8. Ahlmann E., Patzakis M., Roidis N., Shepherd L., and Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 84 (2002) 716-720
9. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., and Davino N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329 (1996) 300-309
10. Seiler J.G., and Johnson J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 9 (2000) 91-97
11. Sawin P.D., Traynelis V.C., and Menezes A.H. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 88 (1998) 255-265
12. Dimar J.R., Glassman S.D., Burkus J.K., and Carreon L.Y. Clinical outcomes and fusion success at two years of single level instrumented posterolateral fusions with rhBMP2/CRM vs. iliac crest bone graft. Spine (2006) 15;31:2534-9
13. Heary R., Schlenk R., Saccieri T., Barone D., and Brotea C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 50 (2005) 510-517
14. Summers B.N., and Eisenstein S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71 (1989) 677-680
15. Frymoyer J.W., Hanley E., Howe J., et al. Disc excision and spine fusion in the management of lumbar disc disease. A minimum ten-year follow-up. Spine 3 (1978) 1-6
16. Ackerman S., Mafilios M., and Polly D. Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Spine 27 (2002) S94-S99
17. Polly D., Ackerman S., Shaffrey C., Ogilvie J.W., and Wang J.C. A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 26 (2003) 1027-1037
18. Boden S.D. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27 suppl 16 (2002) 26-31
19. Carreon L.Y., Glassman S.D., Anekstein Y., et al. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine 30 (2005) E243-E246
20. Neen D., Noyes D., Shaw M., Gwilym S., and Fairlie N. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine 31 (2006) E636-E640
21. Weiner B.K., and Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine 28 (2003) 1968-1970
22. Glassman S., Dimar J., Carreon L., Campbell M., and Puno R. Initial fusion rates with rh-BMP-2 and an HA-TCP/collagen carrier in posterolateral fusion. Spine 30 (2005) 1694-1698